Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 2Glioma 1Colorectal Neoplasms 1Brain Neoplasms 1

Interventions

Radiosurgery 23Temozolomide 14Magnetic Resonance Spectroscopy 14pembrolizumab 11Bevacizumab 11Nivolumab 10Ipilimumab 8Specimen Handling 6Memantine 6abemaciclib 5Radiotherapy 5Mental Status and Dementia Tests 5Blood Specimen Collection 5Radiation 4entrectinib 3Surveys and Questionnaires 3Sodium Chloride 3Saline Solution 3Receptors, Interleukin-8B 3Proton Therapy 3Lomustine 3trastuzumab deruxtecan 2trametinib 2pertuzumab 2osimertinib 2lenvatinib 2fluciclovine F-18 2contrast agent BR1 2atezolizumab 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Sitagliptin Phosphate × 90 days × Clear all
NCT07003542 2026-05-08

A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas

Case Comprehensive Cancer Center

Phase 2 Recruiting
48 enrolled
CNS

Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡